Results 201 to 210 of about 224,992 (367)

Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets

open access: yesMedComm, Volume 6, Issue 7, July 2025.
This review provides a comprehensive overview of common autoimmune diseases, details clinical manifestations and summarizes the pathogenesis, including the breakdown of immune tolerance, initiation of autoimmune responses, and their progressive amplification.
Xiaoshuang Song   +9 more
wiley   +1 more source

A systematic review on the determinants of long‐term kidney sequelae after hypertensive diseases of pregnancy

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 7, Page 1254-1273, July 2025.
This systematic review aimed to evaluate the risk of chronic kidney disease (CKD) after preeclampsia and the determinants of these sequelae. Five authors found a more significant risk of kidney disease after PE, with a risk ranging from two to three times higher.
Marie Haudiquet   +3 more
wiley   +1 more source

Transition From Intraoperative Vancomycin‐Piperacillin Tazobactam to Vancomycin‐Cefepime Does Not Change Acute Kidney Injury or Renal Recovery Outcomes in Patients Undergoing Heart Transplantation

open access: yesClinical Transplantation, Volume 39, Issue 7, July 2025.
ABSTRACT Introduction The impact of empiric intraoperative vancomycin and piperacillin‐tazobactam (VPT) compared to vancomycin and cefepime (VC) on AKI is equivocal, and renal recovery and infection outcomes have not been studied in this context. Further, this has not been studied in patients undergoing orthotopic heart transplantation (OHT).
Ashley L. Golbus   +8 more
wiley   +1 more source

Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono‐ and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double‐blind trial

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 7, Page 3943-3956, July 2025.
Abstract Background Sodium‐glucose cotransporter (SGLT) 2 inhibitors attenuate fasting glomerular hyperfiltration in people with type 2 diabetes (T2D). However, SGLT2‐inhibition increases glucagon levels, which facilitate postprandial hyperfiltration.
Michaël J. B. van Baar   +10 more
wiley   +1 more source

Prevalence of Proteinuria in Dogs With Immune‐Mediated Disease

open access: yesJournal of Veterinary Internal Medicine, Volume 39, Issue 4, July/August 2025.
ABSTRACT Background Proteinuria is associated with autoimmune diseases in humans. There is minimal evidence in the veterinary literature on proteinuria and its association with immune‐mediated disease in dogs. Hypothesis Renal proteinuria is common in dogs with immune‐mediated disease. Dogs presenting with pyrexia or immune‐mediated polyarthritis (IMPA)
James C. Barton   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy